Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Berkeley Lights, Castle Bio, IsoPlexis, More

Berkeley Lights: John Chiminski, Gregory Lucier, Michael Marks

Berkeley Lights has named Greg Lucier as chairperson of the board of directors, effective May 14. He will succeed Michael Marks, who is retiring. John Chiminski will also join the company's board as an independent director.

Lucier is CEO of Corza Health and a former CEO of Life Technologies, acquired by Thermo Fisher Scientific in 2013. He holds an MBA from Harvard Business School.

Chiminski is CEO of pharmaceutical development and manufacturing firm Catalent, a job he has held since 2009. Prior to that, he spent more than 20 years with GE Healthcare, where he held roles including president and CEO of GE Medical Diagnostics, VP and general manager of its global magnetic resonance business, and VP and general manager of healthcare services. He holds master's degrees in electrical engineering from Purdue University and management from Northwestern University.


Castle Biosciences: Tiffany Olson

Castle Biosciences has appointed Tiffany Olson to its board of directors. Olson has served as president of Nuclear & Precision Health Solutions at Cardinal Health since 2013, and served as president of NaviMed prior to that. She has also worked for Eli Lilly and Roche Diagnostics, where she attained the position of president and CEO of Roche Diagnostics Corporation. Olson currently serves as an ambassador with the American Cancer Society through the ResearcHERS: Women Fighting Cancer campaign, which helps fund cancer research led by women, and currently serves on the board of the Council on Radionuclides and Radiopharmaceuticals.


IsoPlexis: Jason Ou

Single-cell proteomics firm IsoPlexis has named Jason Ou as general manager for the Asia-Pacific, or APAC, region. Ou joins IsoPlexis from Tecan, where he was most recently head of market unit commercial operations, APAC, after having previously served as director of OEM business for APAC and OEM components business manager.


For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.